BioSpace News Archive

Reports and Data has recently added a research report Immune Globulin Intravenous Market Size, Trends & Analysis, By Product Type (IVIg Liquid, IVIg Powder), By Application (Immunodeficiency, Autoimmune Disease, Acute Infection), By Region, Forecast To 2027.

The industry analysis report is considered a valuable source of information about the global Renal Cell Cancer Treatment industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The latest market analysis report published by Reports and Data, titled ‘Global Nasal Antihistamines Market – Forecast to 2028,’ thoroughly examines the Nasal Antihistamines industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts

The global thyroid function tests market size is expected to reach USD 2.44 Billion by 2028 at a CAGR of 6.2%, according to the latest report by Reports and Data.

Immunomic Therapeutics, Inc., a privately-held clinical-stage biotechnology company pioneering the study of LAMP -mediated nucleic acid-based immunotherapy announced the appointment of Brian Stamper to Vice President, Cell Therapy Operations.

The latest market analysis report published by Reports and Data, titled ‘Global Ureteral Stents Market – Forecast to 2028,’ thoroughly examines the Ureteral Stents industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts.

Increasing focus on skin care and physical appurtenance, rising aging population across the globe, and rapid adoption of advanced anti-aging treatment and devices in many developed and developing countries are expected to drive global Anti-aging Devices market growth.

Todos Medical, Ltd. (OTCQB: TOMDF), today announced that its majority-owned subsidiary 3CL Pharma, Ltd. reported a Day 28 update from an ongoing case study by Dr. Lee Morgentaler of a 3CL protease cleanse with Tollovid, a 3CL protease inhibitor dietary supplement, in a patient who originally contracted COVID in December 2021 and experienced symptoms of Long COVID, including erectile dysfunction.

Increasing prevalence of infectious diseases across the globe, rising need for effective vaccination against coronavirus, and growing investments for development of novel vaccines are some key factors expected to drive global Vaccine market.

AB Science SA (Euronext - FR0010557264 - AB) today announced publication of results from its positive study of masitinib in severe asthma uncontrolled by oral corticosteroids (OCS) in the peer-reviewed Journal of Asthma and Allergy.